Ma, Shao-lin <br/><br/>
Lapatinib antagonizes multidrug resistance-associated protein 1-mediated multidrug resistance by inhibiting its transport function.  [electronic resource] 

 -  Molecular medicine (Cambridge, Mass.)  Sep 2014 
 - 390-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-3658 
<br/><br/><label>Standard No.: </label>10.2119/molmed.2014.00059  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Biological Transport--drug effects<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Cisplatin--pharmacology<br/>Doxorubicin--pharmacology<br/>Drug Resistance, Multiple--drug effects<br/>Drug Resistance, Neoplasm--drug effects<br/>Drug Synergism<br/>Extracellular Signal-Regulated MAP Kinases--metabolism<br/>HEK293 Cells<br/>Humans<br/>Lapatinib<br/>Mice<br/>Mice, Nude<br/>Multidrug Resistance-Associated Protein 2<br/>Multidrug Resistance-Associated Proteins--antagonists & inhibitors<br/>NIH 3T3 Cells<br/>Neoplasms--drug therapy<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Quinazolines--pharmacology<br/>Tumor Burden--drug effects<br/>Vincristine--pharmacology